IM Cannabis (IMCC) Stock

IM Cannabis Corp. (IMCC) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.84. This compares to loss of $1.14 per share a year ago.

Toronto, Ontario--(Newsfile Corp. - Le 9 juillet/July 2024) - IM Cannabis Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every six (6) pre-consolidated common shares. As a result, the outstanding shares of the company will be reduced to approximately 2,232,357 common shares.

IMC Germany's accelerated growth potential leans strongly on its supply strategy through its ability to partner with cannabis growers for EU-GMP certification, bolstering the company's supply chain with exclusive product TORONTO and GLIL YAM, Israel , June 5, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is experiencing accelerated growth in Germany after the April 1 st partial legalization, further to the Company's press release dated March 25, 2024. Adjupharm GmbH's, IMC's German subsidiary ("Adjupharm" or "IMC Germany"), is supporting its growth by further bolstering its supply chain with an additional EU-GMP supplier, GlassHouse Botanics Inc. ("GlassHouse Botanics"), headquartered in Whitewater, Ontario.

IM Cannabis stock is surging on Wednesday after reports surfaced that President Joe Biden's Administration intends to reclassify marijuana from Schedule I to Schedule III.

Marijuana stock investors are keeping their focus on the future. But why some may ask? With the cannabis sector being so volatile several things will need to take place for better trading. All of this will need to happen in the near to far future for stronger confidence regarding cannabis investing. This year we have seen a continuation of growth in the form of revenue and an increase in demand for more cannabis products.

IM Cannabis Corp. (IMCC) Q4 2023 Earnings Call Transcript

The cannabis industry over the last several years has seen tremendous growth. Many companies through ups and downs are seeing stronger sales. Recently companies have been reporting their earnings and the profits are high for most. This success has helped drive some much-needed moments into the stock market for certain marijuana stocks. Often when the news is impactful enough it can help how some cannabis stocks perform.

Even with the amount of progress the cannabis industry has seen investing in legal cannabis comes with big risks. As many know cannabis is now legal in more than 30 states in the US. This emerging industry has consistently generated over a billion in revenue. Not to mention it has employed many people who are looking for work. There seem to be more positives than negatives regarding legal cannabis so why is investing so risky?

IM Cannabis Corp. (NASDAQ:IMCC ) Q3 2023 Results Conference Call November 13, 2023 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chief Executive Officer Itay Vago - Chief Financial Officer Conference Call Participants Scott Fortune - ROTH MKM Aaron Grey - Alliance Global Operator Good morning. And welcome to IM Cannabis' Third Quarter 2023 Earnings Conference Call.